Phase Forward has announced a multi-year, multi-million dollar extension of its existing partnership with CRO SGS. The agreement reinforces the companies’ close working relationship and offers SGS’s customers the benefits of Phase Forward’s InForm Global Trial Management (GTM), Clarix Interactive Response Technology (IRT) and Maaguzi Web-based electronic patient reported outcomes (ePRO) and late phase solutions.
Luc Braeken, global director of biometrics services at SGS, said: “Our customers are looking for an integrated eClinical solution comprising multiple systems. The agreement announced today will allow us to respond to customer demand for this integrated solution with innovative product sets from a market leader. This solution is designed to meet the needs of even the most demanding clinical development professional, offering more effective ways to manage clinical operations, help ensure product safety and reduce time-to-market.”
Mike Davies, vice president of global CRO partnerships at Phase Forward, said: “We look forward to building on the success of our collaboration to date with the solutions that our acquisitions of Clarix and Maaguzi add to the equation.”
